跳至主要内容
临床试验/EUCTR2013-004629-96-DK
EUCTR2013-004629-96-DK进行中(未招募)不适用

Diagnostic Modalities in Nuclear Medicine in Well-Differentiated Thyroid Cancer - DIAMONDT

Department of Nuclear Medicine, Odense University Hospital0 个研究点目标入组 100 人开始时间: 2014年4月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients with well-differentiated thyroid carcinoma referred for I-131 radioiodine therapy
  • - 18 years or older
  • - Written consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • - Pregnancy or breast feeding
  • - Inability to comply with instructions
  • - A body weight greater than 150 kg.
  • - Reduced kidney function (defined as increased S-Creatinine or diagnosed kidney disease).
  • - Lactose intolerance
  • - Leukopenia, urinary incontinence, dysphagia, oesophageal stricture, active gastritis, gastric erosions and peptic ulcer and suspected reduced gastrointestinal motility

研究者

发起方
Department of Nuclear Medicine, Odense University Hospital

相似试验

Examination and comparison of imaging procedures in... | 临床试验